Works matching IS 08991987 AND DT 2022 AND VI 61 AND IP 11
Results: 8
Metabolomics‐based classification reveals subtypes of hepatocellular carcinoma.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 989, doi. 10.1002/mc.23455
- By:
- Publication type:
- Article
CCT4 knockdown enhances the sensitivity of cisplatin by inhibiting glycolysis in human esophageal squamous cell carcinomas.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 1043, doi. 10.1002/mc.23460
- By:
- Publication type:
- Article
Therapeutic potential of the novel Bcl‐2/Bcl‐X<sub>L</sub> dual inhibitor, APG1252, alone or in combination against non‐small cell lung cancer.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 1031, doi. 10.1002/mc.23458
- By:
- Publication type:
- Article
ARHGEF40 promotes non‐small cell lung cancer proliferation and invasion via the AKT‐Wnt axis by binding to RhoA.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 1016, doi. 10.1002/mc.23457
- By:
- Publication type:
- Article
Urinary parabens and breast cancer risk: Modification by LINE‐1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 1002, doi. 10.1002/mc.23456
- By:
- Publication type:
- Article
Divergence of mutational signatures in association with breast cancer subtype.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 1056, doi. 10.1002/mc.23461
- By:
- Publication type:
- Article
E2F7 enhances hepatocellular carcinoma growth by preserving the SP1/SOX4/Anillin axis via repressing miRNA‐383‐5p transcription.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 975, doi. 10.1002/mc.23454
- By:
- Publication type:
- Article
Issue Information ‐ Ed Board.
- Published in:
- Molecular Carcinogenesis, 2022, v. 61, n. 11, p. 973, doi. 10.1002/mc.23321
- Publication type:
- Article